drugset / Trial / NCT03985462
Very Small Embryonic-like Stem Cells for Ovary
Phase 1/2
Withdrawn
Fuda Cancer Hospital, Guangzhou
Guangzhou Four-Leaf Clover HealthTech Co., Ltd. · collab
RandomizedParallel-groupSingle-blindTreatment
Summary
The aim of this study is the safety and efficacy of autologous very small embryonic-like stem cells(VSELs) to premature ovarian failure.
Timeline
- Start
- 2019-07-03
- Primary completion
- 2020-05-30
- Completion
- 2020-06-30
Outcome
Outcome not reported
Stopped: “Policy changes have contributed to the failure to carry out smoothly”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | very small embryonic-like stem cell | Cell therapy | 100000 cells | Other |
| Subject | very small embryonic-like stem cell | Cell therapy | 200000 cells | Other |
| Subject | very small embryonic-like stem cell | Cell therapy | 300000 cells | Other |